Insulin-like Growth Factor Pathway Genetic Polymorphisms, Circulating IGF1 and IGFBP3, and Prostate Cancer Survival.
Cao Y., Lindström S., Schumacher F., Stevens VL., Albanes D., Berndt SI., Boeing H., Bas Bueno-de-Mesquita H., Canzian F., Chamosa S., Chanock SJ., Diver WR., Gapstur SM., Gaziano JM., Giovannucci EL., Haiman CA., Henderson B., Johansson M., Marchand LL., Palli D., Rosner B., Siddiq A., Stampfer M., Stram DO., Tamimi R., Travis RC., Trichopoulos D., Willett WC., Yeager M., Kraft P., Hsing AW., Pollak M., Lin X., Ma J.
The insulin-like growth factor (IGF) signaling pathway has been implicated in prostate cancer (PCa) initiation, but its role in progression remains unknown.